143 related articles for article (PubMed ID: 23867029)
21. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.
Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):121-37. PubMed ID: 19287307
[TBL] [Abstract][Full Text] [Related]
22. A comparison of live counseling with a web-based lifestyle and medication intervention to reduce coronary heart disease risk: a randomized clinical trial.
Keyserling TC; Sheridan SL; Draeger LB; Finkelstein EA; Gizlice Z; Kruger E; Johnston LF; Sloane PD; Samuel-Hodge C; Evenson KR; Gross MD; Donahue KE; Pignone MP; Vu MB; Steinbacher EA; Weiner BJ; Bangdiwala SI; Ammerman AS
JAMA Intern Med; 2014 Jul; 174(7):1144-57. PubMed ID: 24861959
[TBL] [Abstract][Full Text] [Related]
23. Internet programs targeting multiple lifestyle interventions in primary and secondary care are not superior to usual care alone in improving cardiovascular risk profile: a systematic review.
Vegting IL; Schrijver EJ; Otten RH; Nanayakkara PW
Eur J Intern Med; 2014 Jan; 25(1):73-81. PubMed ID: 24011771
[TBL] [Abstract][Full Text] [Related]
24. A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids and Coronary Heart Disease Risk.
Alexander DD; Miller PE; Van Elswyk ME; Kuratko CN; Bylsma LC
Mayo Clin Proc; 2017 Jan; 92(1):15-29. PubMed ID: 28062061
[TBL] [Abstract][Full Text] [Related]
25. The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis.
Gupta BP; Murad MH; Clifton MM; Prokop L; Nehra A; Kopecky SL
Arch Intern Med; 2011 Nov; 171(20):1797-803. PubMed ID: 21911624
[TBL] [Abstract][Full Text] [Related]
26. The role of noninvasive cardiovascular testing, applied clinical nutrition and nutritional supplements in the prevention and treatment of coronary heart disease.
Houston M
Ther Adv Cardiovasc Dis; 2018 Mar; 12(3):85-108. PubMed ID: 29316855
[TBL] [Abstract][Full Text] [Related]
27. [Efficacy of an intensive prevention programme of coronary heart disease: 5 year follow-up outcomes].
Muñoz MA; Subirana I; Ramos R; Franzi A; Vila J; Marrugat J;
Med Clin (Barc); 2008 Apr; 130(14):521-5. PubMed ID: 18457617
[TBL] [Abstract][Full Text] [Related]
28. The response to receiving phenotypic and genetic coronary heart disease risk scores and lifestyle advice - a qualitative study.
Shefer G; Silarova B; Usher-Smith J; Griffin S
BMC Public Health; 2016 Dec; 16(1):1221. PubMed ID: 27914472
[TBL] [Abstract][Full Text] [Related]
29. Secondary prevention of coronary heart disease.
Zafari AM; Wenger NK
Arch Phys Med Rehabil; 1998 Aug; 79(8):1006-17. PubMed ID: 9710178
[TBL] [Abstract][Full Text] [Related]
30. Gender differences in secondary prevention of coronary heart disease: reasons to worry or not?
Nilsson P; Brandström H; Lingfors H; Erhardt L; Hedbäck B; Israelsson B; Sjöberg G;
Scand J Prim Health Care; 2003 Mar; 21(1):37-42. PubMed ID: 12718459
[TBL] [Abstract][Full Text] [Related]
31. Preventing coronary heart disease: the implementation of healthy lifestyle strategies for children and adolescents.
Hayman LL; Reineke PR
J Cardiovasc Nurs; 2003; 18(4):294-301. PubMed ID: 14518605
[TBL] [Abstract][Full Text] [Related]
32. Risk factor modification through nonpharmacological interventions in patients with coronary heart disease.
Sebregts EH; Falger PR; Bär FW
J Psychosom Res; 2000; 48(4-5):425-41. PubMed ID: 10880664
[TBL] [Abstract][Full Text] [Related]
33. Realising the potential of the family history in risk assessment and primary prevention of coronary heart disease in primary care: ADDFAM study protocol.
Qureshi N; Armstrong S; Saukko P; Sach T; Middlemass J; Evans PH; Kai J; Farrimond H; Humphries SE
BMC Health Serv Res; 2009 Oct; 9():184. PubMed ID: 19821989
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular disease prevention.
Keevil JG; Stein JH; McBride PE
Prim Care; 2002 Sep; 29(3):667-96. PubMed ID: 12529904
[TBL] [Abstract][Full Text] [Related]
35. What is killing? People's knowledge about coronary heart disease, attitude towards prevention and main risk reduction barriers in Ismailia, Egypt (descriptive cross-sectional study).
Seef S; Jeppsson A; Stafström M
Pan Afr Med J; 2013; 15():137. PubMed ID: 24319527
[TBL] [Abstract][Full Text] [Related]
36. Systematic review of the effect of diet and exercise lifestyle interventions in the secondary prevention of coronary heart disease.
Cole JA; Smith SM; Hart N; Cupples ME
Cardiol Res Pract; 2010 Dec; 2011():232351. PubMed ID: 21197445
[TBL] [Abstract][Full Text] [Related]
37. Quantifying the dose-response of walking in reducing coronary heart disease risk: meta-analysis.
Zheng H; Orsini N; Amin J; Wolk A; Nguyen VT; Ehrlich F
Eur J Epidemiol; 2009; 24(4):181-92. PubMed ID: 19306107
[TBL] [Abstract][Full Text] [Related]
38. Patients' Experiences of Cardiovascular Health Education and Risk Communication: A Qualitative Synthesis.
Mentrup S; Harris E; Gomersall T; Köpke S; Astin F
Qual Health Res; 2020 Jan; 30(1):88-104. PubMed ID: 31729937
[TBL] [Abstract][Full Text] [Related]
39. A qualitative descriptive study of risk reduction for coronary disease among the Hong Kong Chinese.
Chan CW; Lopez V
Public Health Nurs; 2014; 31(4):327-35. PubMed ID: 24117891
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
